PCVX Insider Trading
Insider Ownership Percentage: 3.10%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $29,335,318.37
Vaxcyte Share Price & Price History
Current Price: $30.65
Price Change: ▲ Price Increase of +1.53 (5.25%)
As of 04/17/2025 05:00 PM ET
Vaxcyte Insider Trading History
Vaxcyte Institutional Trading History
Data available starting January 2016
Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine for the prevention of invasive pneumococcal disease. The company also develops VAX-31 to protect against emerging strains and to help address antibiotic resistance; VAX-A1, a novel conjugate vaccine candidate to prevent disease caused by Group A Streptococcus; VAX-PG, a novel protein vaccine candidate targeting keystone pathogen responsible for periodontitis; and VAX-GI to prevent Shigella, a bacterial illness. The company was formerly known as SutroVax, Inc. and changed its name to Vaxcyte, Inc. in May 2020. Vaxcyte, Inc. was incorporated in 2013 and is headquartered in San Carlos, California.
Read More on Vaxcyte
Today's Range
Now: $30.65
52 Week Range
Now: $30.65
Volume
1,724,222 shs
Average Volume
1,218,023 shs
Market Capitalization
$3.95 billion
P/E Ratio
N/A
Dividend Yield
N/A
Beta
1.26
Who are the company insiders with the largest holdings of Vaxcyte?
Vaxcyte's top insider shareholders include:
- Grant Pickering (CEO)
- Jim Wassil (COO)
- Andrew Guggenhime (CFO)
- Mikhail Eydelman (SVP)
- Elvia Cowan (SVP)
- Teri Loxam (Director)
- Halley E Gilbert (Director)
- Heath Lukatch (Director)
Learn More about top insider investors at Vaxcyte.
Who are the major institutional investors of Vaxcyte?
Which major investors are buying Vaxcyte stock?
In the last quarter, PCVX stock was bought by institutional investors including:
- Assenagon Asset Management S.A.
- GAMMA Investing LLC
- Rhumbline Advisers
- SG Americas Securities LLC
- Handelsbanken Fonder AB
- Harbor Capital Advisors Inc.
- Parallel Advisors LLC